Evidence map›Paper›PMID 42393087›Full record

ArticleNature communications2026

Prokaryotic Schlafen proteins cleave tRNAs during type III CRISPR immunity.

Pedro Weickert, Yang Liu, Jonathan Strecker

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Pedro Weickert *Department of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA.ORCID 0009-0001-0653-0630
Yang Liu *Department of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA.
Jonathan StreckerDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA. strecker@molbio.mgh.harvard.edu.ORCID 0000-0001-8953-5615

Funding

Discovery and characterization of programmable biological systemsDP2HL185100 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI STRECKER, JONATHAN · 2025 to 2025
$1.5M
NHLBI NIH HHS DP2 HL185100U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) DP2HL185100
6 · The paper itself

Abstract

Schlafen nucleases restrict viral infection in mammals by cleaving self RNAs, however, their function and mechanism in prokaryotic immunity is unknown. Here, we uncover CRISPR-associated Schlafen (Cash) proteins containing a Schlafen domain fused to Csx15, an uncharacterized member of Rossmann-like nucleotide-binding sensors. Cash is activated by cyclic tetra-adenylate (cA₄) produced during type III CRISPR interference and induces cell toxicity by cleaving tRNAs, primarily in the T-loop. Cryo-electron microscopy structures of Chloroflexi bacterium Cash reveal an inactive dodecamer, the formation of a filament upon cA₄ binding to align catalytic interfaces, and the molecular basis of substrate recognition and cleavage in a tRNA-bound complex. We identify numerous families of prokaryotic Schlafen proteins associated with diverse antiviral defense systems and characterized by unique sensor domains. This work highlights tRNA depletion by Schlafen nucleases as an evolutionary recurring antiviral strategy and reveals mechanistic differences between Cash and human Schlafen members.

Indexed as

Bacterial ProteinsClustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Associated ProteinsCRISPR-Cas SystemsRNA, TransferCryoelectron MicroscopyHumansBacterial ProteinsCRISPR-Associated ProteinsRNA, Transfer

Identifiers

PMID42393087
PMCPMC13462974

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.